Antares Pharma, Inc. · Ewing, NJ United States (NYSE Amex: AIS)
| 250 Phillips Blvd., Ste. 290 | Phone: 609-359-3020 |
| Ewing, NJ | Fax: 609-359-3015 |
| 08618 | |
| United States | 
Map This Company |
Antares Pharma, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Antares Pharma understands antagonism towards needles. The company develops needle-free systems for administering injectable drugs. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Vision system is used primarily for the delivery of insulin and of human growth hormones; it is available over-the-counter and by prescription in the US and is also sold overseas. In addition to its needle-free systems, the company develops other drug-delivery platforms, including topical gels, orally administered disintegrating tablets, and mini-needle injection systems.
Antares Pharma, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NYSE Amex: AIS Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 21 |
Executives
18 executives listed for Antares Pharma, Inc.'s Ewing, NJ location.
| Chairman | Leonard Jacob | |
|---|---|---|
| President, CEO, and Director | Paul Wotton | |
| EVP, CFO, Corporate Secretary; President, Parenteral Products | Robert Apple |